"MIRO" Molecularly Oriented Immuno-radio-therapy

Clinical trial NCT02710643 · COMPLETED

Trial details

NCT number: NCT02710643
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Grade 3A

Start date: 2014-10-01
Primary completion: 2018-04-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.